Ihowuliseleli OEM China CE Ephawulweyo SARS Antigen Rapid Uvavanyo Colloidal Gold

inkcazelo emfutshane:


  • Ixesha lovavanyo:Imizuzu eyi-10-15
  • Ixesha elisebenzayo:Iinyanga ezingama-24
  • Ukuchaneka:Ngaphezulu kwe-99%
  • Inkcazo:1/25 uvavanyo / ibhokisi
  • Ubushushu bokugcina :2℃-30℃
  • :
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    Inkampani yethu igxininisa kumgaqo-nkqubo womgangatho “womgangatho olungileyo wemveliso sisiseko sokusinda kweshishini; ukuzaliseka komthengi kuya kuba yindawo yokujonga kunye nesiphelo senkampani; Uphuculo oluzingisileyo kusukelo lwanaphakade lwabasebenzi” kunye nenjongo engaguqukiyo “yodumo kuqala, umthengi kuqala” kwiWholesale yeOEM yaseTshayina CE Ephawulwe yi-SARS Antigen Rapid Test Colloidal Gold, Asize siyeke ukuphucula ubuchule bethu kunye nomgangatho ophezulu ukuze sihambisane nazo zonke ukukhula kolu shishino kunye nokuhlangabezana nokwaneliseka kwakho ngokufanelekileyo. Ukuba unomdla kwizisombululo zethu, nceda uqhagamshelane nathi ngokukhululekileyo.
    Inkampani yethu igxininisa kumgaqo-nkqubo womgangatho “womgangatho olungileyo wemveliso sisiseko sokusinda kweshishini; ukuzaliseka komthengi kuya kuba yindawo yokujonga kunye nesiphelo senkampani; Uphuculo oluzingisileyo kusukelo lwanaphakade lwabasebenzi” kunye nenjongo engaguqukiyo “yodumo kuqala, abathengi kuqala”China SARS Antigen Test, Uvavanyo lwe-SARS-C0V2, Ngoku sicinge ngokunyanisekileyo ukunika i-arhente yophawu kwiindawo ezahlukeneyo kwaye umda wengeniso ye-arhente yeyona nto ibalulekileyo esiyikhathaleleyo. Wamkelekile bonke abahlobo kunye nabathengi ukuba bazibandakanye nathi. Sele sikulungele ukwabelana win-win corporation.
    CEA

    ikhola_conew1

     

    Iimveliso Iinkcukacha ikhowudi iyunithi uluhlu lomgca uluhlu lwereferensi Uluhlu lomgca
    Ikhithi yokuxilonga yeCarcino-embryonic antigen 25T/Ibhokisi Cea ng/ml 2-500 5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     


  • Ngaphambili:
  • Okulandelayo: